Literature DB >> 10312255

Applications of cost-benefit analysis to health care. Departures from welfare economic theory.

S Birch, C Donaldson.   

Abstract

In applying the principles of cost-benefit analysis to real world problems of resource allocation particular care must be taken to ensure that the welfare economic theory which underlies the cost-benefit technique is adhered to. Major problems arise where costs and benefits are used interchangeably to represent the good and bad attributes of a programme. Furthermore, in the presence of mutually exclusive projects, focussing attention upon the net benefits (or cost-benefit ratios) of individual projects as opposed to the net benefits of the use of budgeted resources can lead to biased estimates of the shadow price of projects and, consequently, errors in analysts' conclusions. As a result, economic appraisals of individual projects are not directly relevant for choosing between mutually exclusive projects of different sizes. Both types of problem are illustrated by reference to both simple examples and published economic appraisals of health care techniques. Integer programming is proposed and demonstrated as a method of selecting between mutually exclusive projects.

Mesh:

Year:  1987        PMID: 10312255     DOI: 10.1016/0167-6296(87)90009-9

Source DB:  PubMed          Journal:  J Health Econ        ISSN: 0167-6296            Impact factor:   3.883


  13 in total

Review 1.  Recent advances in the methods of cost-benefit analysis in healthcare. Matching the art to the science.

Authors:  E McIntosh; C Donaldson; M Ryan
Journal:  Pharmacoeconomics       Date:  1999-04       Impact factor: 4.981

2.  Estimating the "avoidable" burden of disease by Disability Adjusted Life Years (DALYs).

Authors:  S Hollinghurst; G Bevan; C Bowie
Journal:  Health Care Manag Sci       Date:  2000-01

Review 3.  The (near) equivalence of cost-effectiveness and cost-benefit analyses. Fact or fallacy?

Authors:  C Donaldson
Journal:  Pharmacoeconomics       Date:  1998-04       Impact factor: 4.981

4.  Cost-per-QALY league tables: their role in pharmacoeconomic analysis.

Authors:  J M Mason
Journal:  Pharmacoeconomics       Date:  1994-06       Impact factor: 4.981

Review 5.  Information created to evade reality (ICER): things we should not look to for answers.

Authors:  Stephen Birch; Amiram Gafni
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

Review 6.  Conducting economic evaluations of screening and brief intervention for hazardous drinking: Methods and evidence to date for informing policy.

Authors:  Alexander J Cowell; Jeremy W Bray; Michael J Mills; Jesse M Hinde
Journal:  Drug Alcohol Rev       Date:  2010-11

Review 7.  Computer Rx: more harm than good?

Authors:  R Wall
Journal:  J Med Syst       Date:  1991-12       Impact factor: 4.460

8.  Technology assessment and cost-effectiveness analysis: misguided guidelines?

Authors:  C D Naylor; J I Williams; A Basinski; V Goel
Journal:  CMAJ       Date:  1993-03-15       Impact factor: 8.262

9.  Guidelines for the adoption of new technologies: a prescription for uncontrolled growth in expenditures and how to avoid the problem.

Authors:  A Gafni; S Birch
Journal:  CMAJ       Date:  1993-03-15       Impact factor: 8.262

10.  Some guidelines on the use of cost effectiveness league tables.

Authors:  J Mason; M Drummond; G Torrance
Journal:  BMJ       Date:  1993-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.